AVAH
Aveanna Healthcare Holdings Inc.
AVAH has the edge over UNH overall, supported by stronger fundamentals and stronger valuation.
UNH
UnitedHealth Group Incorporated
UNH has lower modeled downside risk, despite its lower overall score.
AVAH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Under pressure |
AVAH's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AVAH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $9.24 | -25% |
| Current | 8.7x | $12.24 | — |
| Forward | 14x | $12.24 | — |
| Fair | 21x | $29.51 | +141% |
| Expensive | 108x | $151 | +1130% |
Historical ranges are pointers, not guarantees.
AVAH has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
AVAH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for AVAH, with profitability improving.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AVAH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | -37% |
| Q3 2026 | $1.40 | +278% |
| Q2 2026 | $1.26 | +1300% |
| Q1 2026 | $1.21 | +3933% |
| Q4 2025 | $1.05 | +$1.11 |
| Q3 2025 | $0.37 | +$0.71 |
| Q2 2025 | $0.09 | +$0.75 |
| Q1 2025 | $0.03 | +$0.63 |
| Q4 2024 | -$0.06 | +$0.65 |
AVAH has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
AVAH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $695.5M | +12% |
| Q2 2026 | $670.5M | +14% |
| Q1 2026 | $647.9M | +16% |
| Q4 2025 | $662.5M | +27% |
| Q3 2025 | $621.9M | +22% |
| Q2 2025 | $589.6M | +17% |
| Q1 2025 | $559.2M | +14% |
| Q4 2024 | $519.9M | +8.6% |
AVAH has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +3.4 points |
| Q2 2026 | 12% | -1.7 points |
| Q1 2026 | 11% | +1.4 points |
| Q4 2025 | 11% | +1.9 points |
| Q3 2025 | 8.6% | +1.9 points |
| Q2 2025 | 14% | +6.2 points |
| Q1 2025 | 9.3% | +4.6 points |
| Q4 2024 | 8.8% | +2.7 points |
AVAH has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
AVAH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $72.2M | +118% |
| Q2 2026 | $80.9M | +57% |
| Q1 2026 | $4.3M | +$13M |
| Q4 2025 | $49.7M | +271% |
| Q3 2025 | $33.2M | +13% |
| Q2 2025 | $51.6M | +2751% |
| Q1 2025 | -$8.6M | +$3.3M |
| Q4 2024 | $13.4M | +$16.4M |
AVAH has the edge over UNH on cash flow, with more consistent year-over-year improvement.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
AVAH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +4.4M shares |
| 1 year | +3.1% | +7M shares |
| 3 years | +21% | +40.1M shares |
| 5 years | +29% | +51.5M shares |
| Available history | +27% | +49.1M shares |
AVAH has 229M diluted shares, up 3.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over AVAH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
AVAH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.5x | Elevated |
| Q2 2026 | 4.2x | High |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 4.1x | High |
| Q3 2025 | 4.8x | High |
| Q2 2025 | 5.3x | High |
| Q1 2025 | 6.7x | High |
| Q4 2024 | 8.0x | High |
AVAH's net debt is about 3.5 years of its operating earnings (EBITDA), down from 4.8 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over AVAH on leverage, with a lower net debt burden relative to earnings.
AVAH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 69.3 | Neutral |
AVAH's weekly RSI is 58 (neutral) and its Stochastic is 69 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AVAH PE vs Healthcare Sector
| Metric | AVAH | Sector median | Relative |
|---|---|---|---|
| PE | 8.7x | 26x | 66% below |
| PE % | 27 | 36 | 9 pts below |
AVAH has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
AVAH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.7 | 3.6% below |
| 20 week MA | $11.9 | 2.6% above |
| 50 week MA | $9.34 | 31% above |
| 100 week MA | $7.66 | 60% above |
| 200 week MA | $5.12 | 139% above |
AVAH's trend is up, with a small recent dip: it's below only its 8-week average, and 139% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
AVAH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.7 | $7.07 | -39% |
| 2022 | $7.07 | $0.77 | -89% |
| 2023 | $0.77 | $2.68 | +248% |
| 2024 | $2.68 | $4.66 | +74% |
| 2025 | $4.66 | $8.62 | +85% |
| 2026 YTD | $8.62 | $12.2 | +42% |
AVAH has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.